Contraceptive Drugs and Devices Market: Current Analysis and Forecast (2021-2027)

$3500$6860

Emphasis on Products [Drugs (Oral Contraceptives, Topical Contraceptives, Contraceptive Injectable), Devices (Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, IUDs, Other Devices)]; Gender (Male, Females); Distribution Channel (Hospital & Clinics, Retail Pharmacy, Online Pharmacy, Others), and Region & Country

Pages:

182

Table:

51

Figure:

96

Report ID:

UMHE21213

Geography:

Clear
  Get a Sample
SKU: UMHE21213 Categories: , Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
Report Description
Table of content
Research Methodology

Report Description

Contraceptive Drugs and Devices Market was valued at ~US$ 25 billion in 2020 and is expected to grow at a CAGR of ~6% over the forecast period (2021-2027). Contraception is the use of agents, drugs, devices, surgical procedures, for the prevention of unwanted pregnancy. Various devices, along with treatments, are available for both women and men. The effectiveness of the method depends on how carefully a method has been used. For instance, the use of the contraceptive pill is a 99% efficient method but still 9 women every year become pregnant while using this method. The demand for contraceptive drugs and devices is increasing as to avoid the unintended pregnancies and awareness amongst people regarding contraceptive pills. However, some of the restraints in the market include the side effects associated with the use of contraceptive drugs and the high cost of devices and treatments. Contraceptive pills contain the combination of estrogen and progesion in very low-dose (10-30 mcg). Minipills are also used as birth control pill that contains progestin only. In 2019, of the 1.9 billion women of reproductive age (15-49 years) living in the world, 1.1 billion needed family planning, they are either current users of contraceptives, 842 million use modern methods of contraception and 80 million use traditional methods or have an unmet need for family planning. 190 million women want to avoid pregnancy and do not use any contraceptive method.

  REQUEST FREE SAMPLE PDF 

The main products that are developed for the contraception are Permanent Sterilization, Long-Acting Reversible Contraceptives (LARC), Contraceptive Injection, Short-Acting Hormonal Methods and Barrier Methods. Every woman once in a lifetime uses contraception except if they are seeking pregnancy, postpartum, or sexually inactive. Women mainly prefer having contraception pills. Oral contraceptive pill mainly contains the combination of progestogen and estrogen and is mainly indicated as birth control pill. The benefits associated with the use of contraceptive pills are that the menstrual bleeds become regular and less painful, risk of ovarian cancer, premenstrual syndrome, acne is reduced, and protects against pelvic inflammatory diseases.

Value Chain of Global Contraceptive Drugs and Devices Market

 

Insights Presented in the Report

Based on product type the market is bifurcated into drug and devices.

“Amongst Drugs, Oral Contraceptives segment holds the major market share in 2020”

Based on drugs the global Contraceptive drugs and devices market is bifurcated into Oral Contraceptives, Topical Contraceptives and Contraceptive Injectable. Among all, oral contraceptives segment hold the major share due to the following reasons including 99% effictiveness rate for the prevention of unwanted pregnancy, easy to intake, easily available as over-the-counter oral contraceptives and inexpensive.

“Amongst Devices, Condoms segment holds the major share.”

Contraceptive Devices are bifurcated into Condoms, Diaphragms, Cervical Caps, Sponges Vaginal Rings, and IUD. Condoms segment are mainly used among the working age population as a method to prevent unwanted pregnancies, increase cases of STDs, and an increasing government initiatives to reduce population among others.

“Amongst Gender, both Male and Females are anticipated to grow at significant pace”

Based on Gender, the global Contraceptive drugs and devices market is divided into Male and Female. The Male subsegment grabbed the major market owing to the increase in commercialization of male birth control Devices such as contraceptive injection for men. The female subsegment grabbed the major market owing to an increase in unwanted pregnancies and government initiatives.

Amongst Distribution Channel, the Retail Pharmacy holds the major share”

Based on the distribution channel, the global Contraceptive drugs and devices market is segmented into Hospital & Clinics, Retail Pharmacies, Online Pharmacy, and Others. The retail pharmacy is expected to be the fastest-growing market owing to an increase in over-the-counter purchasing of contraceptive drugs.

“North America signifies one of the largest markets of Contraceptive Drugs and Devices Market.”

For a better understanding of the market dynamics of the Contraceptive Drugs and Devices market, a detailed analysis was conducted for different regions and countries including North America (US, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, UK and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), Rest of World. North America dominated the market on the account of lifestyle changes which are the cause of various acute and chronic diseases, and its robust applications in cryosurgery, hypothermia, transplantation, and vaccination. The boost in the Contraceptive Drugs and Devices market is expected due to a rise in demand from several end-use industries and investments in R&D.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segment and sub-segments
  • Deep dive regional level analysis of the industry

Customization Options:

Contraceptive Drugs and Devices Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

  1.1Market Definitions 
  1.2Objective of the Study
  1.3Limitation 
  1.4Stake Holders 
  1.5Currency Used in Report
  1.6Scope of the Global Contraceptive Drugs and Devices Market Study

 

  2.1Research Methodology for the Global Contraceptive Drugs and Devices Market
   2.1.1Main Objective of the Global Contraceptive Drugs and Devices Market

 

  6.1By Drugs  
   6.1.1Oral Contraceptives
   6.1.2Topical Contraceptives
   6.1.3Contraceptive Injectable
  6.2By Devices  
   6.2.1Condoms 
   6.2.2Diaphragms
   6.2.3Cervical Caps
   6.2.4Sponges 
   6.2.5Vaginal Rings
   6.2.6IUDs 
   6.2.7Other Devices 
  7.1Male   
  7.2Female 
  8.1Hospital & Clinics 
  8.2Retail Pharmacy 
  8.3Online Pharmacy 
  8.4Others

 

  9.1NORTH AMERICA CONTRACEPTIVE DRUGS AND DEVICES MARKET 
   9.1.1United States
   9.1.2Canada 
   9.1.3Rest of North America
  9.2EUROPE CONTRACEPTIVE DRUGS AND DEVICES MARKET 
   9.2.1Germany 
   9.2.2France 
   9.2.3United Kingdom
   9.2.4Spain 
   9.2.5Italy 
   9.2.6Rest of Europe
  9.3ASIA PACIFIC CONTRACEPTIVE DRUGS AND DEVICES MARKET
   9.3.1China 
   9.3.2Japan 
   9.3.3India 
   9.3.4Australia 
   9.3.5Rest of Asia Pacific
  9.4REST OF WORLD CONTRACEPTIVE DRUGS AND DEVICES MARKET 

 

  10.1Drivers  
  10.2Challenges 
  10.3Impact Analysis 
  10.4Market Opportunity

 

  13.1Demand Side Analysis
  13.2Supply Side Analysis
   13.2.1Top Product Launches
   13.2.2Top Business Partnerships
   13.2.3Top Business Expansions, Investments and Divestitures
   13.2.4Top Merger and Acquisitions

 

  15.1Porter’s Five Forces Analysis
   15.1.1Bargaining power of Supplier
   15.1.2Bargaining power of Buyer
   15.1.3Industry Rivalry
   15.1.4Availability of Substitute
   15.1.5Threat of new Entrants
  15.2Competitive Landscape
   15.2.1Company Shares, By Revenue
  16.1Bayer AG   
  16.2Pfizer Inc  
  16.3Teva Pharmaceutical Industries Ltd
  16.4Merck & Co. Inc. 
  16.5Mylan NV 
  16.6Allergan Plc.  
  16.7Agile Therapeutics  
  16.8Piramal Enterprises Ltd
  16.9GlaxoSmithKline PLC 
  16.10Johnson & Johnson  
  16.11Novartis AG  
  16.12Sanofi 

 

Research Methodology

Analyzing the historical market, estimation of the current market, and forecasting the future market of the Global Contraceptive Drugs and Devices were the three major steps undertaken to create and analyze the overall adoption and penetration of Contraceptives across major end-users and customers incouding Hospital & Clinics, Retail Pharmacy, Online Pharmacy and Others. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the Contraceptive Drugs and Devices industry. Post assumption and validation of market numbers through primary interviews, a bottom-up approach was applied to forecast the complete market size pertaining to 2027F. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detailed secondary study was conducted to obtain the historical market size of the Contraceptive Drugs and Devices through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.  

Step 2: Market Segmentation:

After obtaining the historical market size of the Contraceptive Drugs and Devices, a detailed secondary analysis was conducted to gather historical market insights and share for different segments and sub-segments for prospect and major markets. Major segments included in the report are Products,type (drug and devices); Gender; and Distribution channel. Further country-level analyses were conducted to evaluate the overall adoption of Contraceptive Drugs and Devices in every region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of Contraceptive Drugs and Devices. Further, we conducted factor analysis using dependent and independent variables such as increasing demand for constraceptive drugs and devices, government initiative to reduct population etc. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, merger and acquisition, business expansion, and product launches in the Contraceptive Drugs and Devices industry across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the Contraceptive Drugs and Devices market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the bottom-up approach was applied to arrive at the market forecast about 2027F for different segments and sub-segments across the major prospect markets. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value (USD) and the adoption rate of Contraceptive Drugs and Devices across the major potential markets globally
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the Contraceptive Drugs and Devices market in terms of services offered. Also, the growth strategies adopted by these players to compete in the fast-growing market.

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the Contraceptive Drugs and Devices market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of Products (drug and devices), Gender and Distribution channel and region/country.

Main Objective of the Contraceptive Drugs and Devices Market Study

The current & future market trends of Contraceptive Drugs and Devices were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends would determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of Contraceptive Drugs and Devices in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include areas of Product type (drugs and devices) Gender, Distribution Channel and Region/country
  • Define and analysis of the regulatory framework for the Contraceptive Drugs and Devices industry
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
  • Major regions studied in the report include North America (US, Canada and Rest of North America), Europe (Germany, France, Italy, Spain, UK and Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of Asia-Pacific), and Rest of the World
  • Company profiles of the Contraceptive Drugs and Devices market and the growth strategies adopted by the market players to sustain in the fast-growing market
  • Deep dive regional level analysis of the industry